GlassScriptPhysician profile
Brian Gerard Golasa
NPI 1811561632
$7,063.69
in general payments reported to CMS, 2019-2025
16 companies · $808 in 2025
The $808 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $323 · 2022: $1,677 · 2023: $2,548 · 2024: $1,708 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,793 · Travel and Lodging: $2,270.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,793.43 |
| Travel and Lodging | $2,270.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,880.86 | 2023-2024 | Actis |
| Pinnacle, INC | $1,335.95 | 2022-2024 | |
| Depuy Synthes Sales INC. | $886.99 | 2021-2025 | Na, Inhance, Fibergraft Bg Morsels |
| Stryker Corporation | $586.82 | 2022-2025 | Pangea, Variax, Axsos |
| Zimmer Biomet Holdings, INC. | $311.43 | 2021-2023 | Rosa |
| Aroa Biosurgery Incorporated | $161.06 | 2025 | |
| Axogen | $159.09 | 2022 | |
| Si-Bone, INC. | $133.99 | 2023 | |
| Integra Lifesciences Corporation | $132.48 | 2023 | Tenoglide |
| Vertex Pharmaceuticals Incorporated | $121.84 | 2025 | |
| Heron Therapeutics, INC. | $111.50 | 2024 | Zynrelef |
| Ortho Development Corporation | $95.28 | 2021 | |
| Encore Medical, LP | $87.28 | 2024 | Djo Surgical |
| Ossur Americas, INC. | $42.23 | 2025 | Unloader One X |
| Kci USA, INC. | $12.84 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| My01 INC. | $4.05 | 2023 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Golasa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.